Radiation oncology firm Nucletron has received 510(k) approval from the U.S. Food and Drug Administration (FDA) for two new applicators for interstitial gynecologic brachytherapy.
The new Utrecht Interstitial Fletcher and Interstitial Ring applicators feature needles designed for enhanced dose placement without risk to surrounding organs while treating both early and advanced cervical disease, according to the Veenendaal, Netherlands-based firm.
Both the Utrecht Interstitial Fletcher and Interstitial Ring applicators are fully CT/MRI compatible and offer enhanced MR visualization, Nucletron said.
Related Reading
Elekta, Nucletron ink Mosaiq deal, May 19, 2009
Nucletron adds to sales in 2008, April 24, 2009
Nucletron to partner with ART on AccuBoost, February 13, 2009
Nucletron receives FDA clearance for RT viewer, November 21, 2008
Nucletron receives Canadian clearance, November 13, 2008
Copyright © 2009 AuntMinnie.com
